Public research footprint of CHU d'Orléans, compiled from the ClinicalTrials.gov public registry.
DLBCL - Diffuse Large B Cell Lymphoma · HIV Antiretroviral Therapy (ART) Adherence · Patients With Bronchopulmonary Cancer · Sickle Cell Disease
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.